Sana Biotechnology adopts revised Code of Business Conduct and Ethics with enhanced conflict-of-interest policies

Sana Biotechnology, Inc.

Board adopted amended Code on October 27, 2022, adding details on potential conflicts of interest.
Revised Code includes policies and procedures for evaluating conflicts involving Board members.
No waivers granted; full text available on company's investor relations website.
Routine governance update with no financial or operational impact.

item 5.05

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Sana Biotechnology, Inc.: 董事会通过了经修订和重述的商业行为和道德准则，包括有关潜在利益冲突的额外讨论。 (effective 2022-10-27).

Change: code of ethics
Effective: 2022-10-27

Exact text from the filing

On October 27, 2022, the Board of Directors (the “ Board ”) of Sana Biotechnology, Inc. (the “ Company ”) adopted the Company’s amended and restated Code of Business Conduct and Ethics (the “ Revised Code of Conduct ”).

View on SEC.gov

Browse all governance changes →

Sana Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-036057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.